TrumpRx Zepbound Price 2026: Full GLP-1 Cost List

What Is TrumpRx.gov?

TrumpRx.gov is a federal website that publishes discounted self-pay prices for brand-name medications from participating manufacturers. It went live on February 5, 2026 with 40 branded medicines from AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer, and the catalog has expanded since. The GLP-1 prices come out of a most-favored-nation pricing framework the administration announced with Eli Lilly and Novo Nordisk in November 2025.

Two mechanics matter more than the prices. First, you can't buy from TrumpRx; it displays a price and hands you to a redemption path, either a participating pharmacy or a channel like LillyDirect. Second, these are cash prices. Running the same fill through insurance is a different transaction at a different number.

How it differs from insurance, LillyDirect, and a savings card

Insurance pays part of a claim and applies the rest to your deductible. A manufacturer savings card cuts a copay on top of commercial insurance and usually excludes anyone on Medicare or Medicaid. TrumpRx is closest to a manufacturer channel like LillyDirect: a published cash price you take to a pharmacy or that channel yourself. If you have insurance, TrumpRx's own product pages tell you to check your copay first, because it may already be lower.

TrumpRx Zepbound Price: The Full Per-Dose Ladder

Zepbound (tirzepatide) has two product pages on TrumpRx, the single-dose vial and the KwikPen, and the self-pay price is the same on both: $299 a month at 2.5mg, $399 at 5mg, and $449 at 7.5mg and every strength above it. The $299 is a starting price attached to the lowest strength, not a flat rate across your titration. Both ladders were read off TrumpRx.gov on August 17, 2026, and both are fulfilled through LillyDirect.

The headline discounts differ only because the pages quote different reference prices: the vial is up to 72% off a $1,087 original at every strength, the KwikPen up to 40% off an original of $499 at 2.5mg through 7.5mg and $699 from 10mg up. Do not run the KwikPen's 40% against $1,087; that suggests roughly $652 a month for a product listed at $299 to $449.

One number to keep straight: $1,087 is the vial page's own comparison price. Lilly separately publishes a wholesale list price of $1,086.37, which our Zepbound cost guide uses. Two real figures from two publishers, not a contradiction.

TrumpRx Mounjaro, Ozempic, and Wegovy Prices (Pens and Tablets)

TrumpRx's sitemap lists eleven GLP-1 product pages in all. Beyond the two Zepbound pages, five carry the drugs most readers arrive looking for: the Mounjaro pen, the Ozempic and Wegovy pens, and an Ozempic and a Wegovy tablet. Two of the pens carry a time-limited introductory rate for new self-pay patients. All figures below were read on TrumpRx.gov on August 17, 2026 and apply to self-pay adults only.

TrumpRx self-pay prices against each brand's stated original price, as listed on August 17, 2026.

The $199 introductory rate on Ozempic and Wegovy applies to new self-pay patients on the two starter strengths only, and TrumpRx states a promotional window of November 17, 2025 through December 31, 2026. After two fills you move onto the standard tier for your strength. For the fuller picture on either molecule, see the Ozempic cost guide, the semaglutide cost guide, the Mounjaro cost guide, or the tirzepatide cost guide. Dose-by-dose modelling lives in the Ozempic, Wegovy, and Mounjaro calculators.

The oral versions are the cheapest entry point on the site, and both start at $149 a month for a 30-count tablet supply. They do not stay there: the Ozempic tablet runs $149 at 1.5mg, $199 at 4mg, and $299 at 9mg, while the Wegovy tablet runs $149 at 1.5mg and 4mg, then $299 at 9mg and 25mg. If you see only the $149 quoted elsewhere, that is the bottom rung, not the price of a maintenance dose.

Each semaglutide tablet page quotes its discount against the matching injectable's list price ($1,027.51 for Ozempic, $1,349.02 for Wegovy), which is why they advertise up to 85% and 89% off. That is how the program references a tablet sharing a molecule with an injectable, not a display error. It is not a blanket rule for oral GLP-1s: Foundayo, below, is quoted against its own price.

The other four GLP-1s on TrumpRx

The remaining four pages get almost no coverage anywhere, and one of them matters more than its obscurity suggests. Foundayo (orforglipron) is the oral GLP-1 that Medicare.gov names first on the Bridge's covered list, so it is the second drug after the Zepbound KwikPen that sits in both programs. On TrumpRx it runs $149 a month at 0.8mg, $199 at 2.5mg, and $299 at 5.5mg and above, against a $649 original, advertised at up to 77% off. Its page also splits pricing by fill period, so confirm your own tier on the product page.

The other three are older molecules. Trulicity (dulaglutide) single-dose pens are $389 a month flat across 0.75, 1.5, 3, and 4.5mg, down from $987.19. Exenatide, listed as the generic for Byetta, is $382.59 for the 5mcg pen-injector and $528.44 for the 10mcg. Liraglutide, the generic for Victoza, is the cheapest GLP-1 on the site at $133.58 for a box of two pens and $184.41 for a box of three. All four were read on TrumpRx.gov on August 17, 2026.

Who Qualifies for TrumpRx Self-Pay Pricing?

The eligibility terms on the Ozempic, Wegovy, Mounjaro, and Zepbound product pages are short. You must be a resident of the United States or a US territory, 18 or older, and hold a valid prescription for the drug. The purchase must be self-pay: you cannot submit it to insurance, you cannot ask an insurer to reimburse you afterwards, and it cannot be applied to an insurance deductible while you are paying the coupon price.

That last clause is the one insured readers underestimate. Paying cash can beat a copay this month and still leave you further from your deductible at year end. If your insurance covers your GLP-1 at all, price both routes across a full plan year, not a single fill.

The four steps between landing on TrumpRx.gov and picking up a filled prescription.

How to use TrumpRx.gov step by step

1. Search TrumpRx.gov for your medication by brand name and open its product page.
2. Select your exact format and strength. Vial and pen prices differ, and the per-dose figure appears only after you choose.
3. Read the eligibility terms on that page and confirm you meet all of them, including the self-pay condition.
4. Follow the redemption path the page gives you. For Lilly products that is a LillyDirect order; for others it is a coupon you take to a participating pharmacy.

TrumpRx and the Medicare GLP-1 Bridge Are Two Separate Programs

If you have seen a $50 GLP-1 price in the news, that figure belongs to the Medicare GLP-1 Bridge, not to TrumpRx.gov. The Bridge is a short-term demonstration run by the Centers for Medicare & Medicaid Services for people enrolled in Medicare Part D. TrumpRx has no Medicare component at all: it is a cash price for anyone who qualifies as a self-pay patient, and you do not reach the Bridge through TrumpRx.gov.

The Bridge runs from July 1, 2026 through December 31, 2027, extended through 2027 because the BALANCE Model is not launching next year. Eligible beneficiaries pay a $50 monthly copay. It operates outside the Part D benefit's normal coverage and payment flow, which has three consequences worth knowing: the Part D deductible does not apply, none of the $50 counts toward your true out-of-pocket total, and there is no low-income subsidy for beneficiaries who normally receive one. CMS uses a single central processor for prior authorization, adjudication, and pharmacy payment in 2026, and plan sponsors do not opt in or carry risk.

On the drug list, Medicare.gov states: "Starting July 1, 2026, Medicare covers these GLP-1 drugs: Foundayo (tablet), Wegovy (injection or tablet), Zepbound (KwikPen only. The program doesn't cover single-dose Zepbound vials or pens)." Ozempic and Mounjaro are not among the three products enumerated there. Separately, a type 2 diabetes diagnosis makes a beneficiary ineligible for the Bridge, because a Part D plan may cover a GLP-1 for that indication instead. Those are two different rules, and merging them is where readers go wrong.

Eligibility is gated on age 18 or older plus a BMI threshold that drops as weight-related conditions stack up, so check the current criteria at medicare.gov/glp1bridge against your own numbers. Four things disqualify you outright: already receiving a GLP-1 through your Part D plan, a type 2 diabetes diagnosis, moderate-to-severe sleep apnea, or fatty liver disease. Prior authorization holds through December 31, 2027 including refills and dose changes unless you switch GLP-1s, and the prescriber certifies you are using it alongside a diet and exercise program. The Bridge is available nationwide and in the territories across Part D plan types.

The TrumpRx Zepbound KwikPen Is the Format That Works in Both Programs

The Medicare GLP-1 Bridge covers the Zepbound KwikPen only, and Medicare.gov says outright that the program does not cover single-dose Zepbound vials or pens. If you had to guess, you would assume that lands Bridge-eligible beneficiaries on the more expensive format. It does not. TrumpRx lists the KwikPen at the same price as the vial at every strength: $299, $399, then $449 from 7.5mg up.

That makes the KwikPen the format with no price downside. A Bridge beneficiary who loses eligibility or needs a cash fill between authorizations pays exactly what a vial user pays. Choose the vial and the Bridge cannot cover it. The KwikPen page also offers a wider fulfilment route: delivery or transfer to a retail pharmacy of your choosing, where the vial page offers delivery only. When both routes are in play, the KwikPen keeps them open.

The two pages look different only because each advertises against its own original, so read the dollar figure for your strength, not the percentage. Once cost is settled, the Mounjaro and Zepbound comparison and the Wegovy and Zepbound comparison cover the clinical side of the choice. Both programs are moving targets. The TrumpRx catalog has expanded at least twice since February 2026, and the Bridge is a demonstration with a scheduled end date. Verify current terms on TrumpRx.gov and cms.gov before you commit to either route.

Is TrumpRx Legit?

Yes, in the narrow sense that matters here: TrumpRx.gov is an official United States government website on a .gov domain, and its prices trace back to agreements the administration announced with Eli Lilly and Novo Nordisk in November 2025. Lilly described the same arrangement in its own investor release, so the figures are corroborated by a company that has to honor them.

Legitimacy isn't the thing to watch. Scope is. TrumpRx doesn't take your money, dispense anything, or verify your prescription; it publishes a price and points you somewhere else. Anything that looks like TrumpRx but asks for payment or a card number on the spot is not TrumpRx. The redemption steps should always land you on a pharmacy or a named manufacturer channel.